Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
Study NCT ID:
NCT00130520
Status:
COMPLETED
Last Update Posted:
2012-05-28
First Post:
2005-08-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
Sponsor:
University of Arizona
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-12
First Submit QC Date:
None
Study First Post Date:
2005-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-13
Results First Submit QC Date:
None
Results First Post Date:
2010-12-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-22
Last Update Post Date:
2012-05-28
Last Update Post Date Type:
ESTIMATED